Urinary sodium excretion and cardiovascular events

JAMA

Volumn 307, Issue 11, 2012, Pages 1138-1139

  Mann, Samuel ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; DIURETIC AGENT;

CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; DIABETES MELLITUS; HUMAN; HYPERTENSION; LETTER; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SODIUM EXCRETION; SODIUM INTAKE; SODIUM RESTRICTION; SODIUM URINE LEVEL;

EID: 84858629627     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2012.326     Document Type: Letter

References (4)

1. O'Donnell MJ, Yusuf S, Mente A, et al. Urinary sodium and potassium excretion and risk of cardiovascular events. JAMA. 2011;306(20):2229-2238.
2. Midgley JP, Matthew AG, Greenwood CM, Logan AG. Effect of reduced dietary sodium on blood pressure: a meta-analysis of randomized controlled trials. JAMA. 1996;275(20):1590-1597. (Pubitemid 26154246)
3. Pimenta E, Gaddam KK, Pratt-Ubunama MN, et al. Relation of dietary salt and aldosterone to urinary protein excretion in subjects with resistant hypertension. Hypertension. 2008;51(2):339-344. (Pubitemid 351159948)
4. He FJ, MacGregor GA. Effect of modest salt reduction on blood pressure: a metaanalysis of randomized trials: implications for public health. J Hum Hypertens. 2002;16(11):761-770. (Pubitemid 36007929)